Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis

Abstract

The authors hypothesized that, similar to the phenomenon described in glioblastoma models, neural stem/progenitor cells that are recruited by the tumor from surrounding brain may exert an antitumorigenic effect.